Exhibit 99.2 IMMUNOPRECISE ANTIBODIES LTD. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS For the three and nine months ended January 31, 2025 and 2024 (Unaudited - Expressed in Canadian Dollars) IMMUNOPRECISE ANTIBODIES LTD. CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited - Expressed in Canadian dollars) | | | January 31, | April 30, | | --- | --- | --- | --- | | | | 2025 | 2024 | | (in thousands) | Note | $|$ | | ASSETS | | | | | Current assets | | | | | Cash | | 12,915 | ...